Bascuas et al., 2018 - Google Patents
Salmonella immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing miceBascuas et al., 2018
View HTML- Document ID
- 6490120409329145173
- Author
- Bascuas T
- Moreno M
- Grille S
- Chabalgoity J
- Publication year
- Publication venue
- Frontiers in immunology
External Links
Snippet
We have previously shown that Salmonella immunotherapy is effective to treat B-cell non- Hodgkin lymphoma (B-NHL) in mice. However, this model involves animals with high tumor burden, whereas in the clinics B-NHL patients are usually treated with chemotherapy …
- 241000607142 Salmonella 0 title abstract description 59
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bascuas et al. | Salmonella immunotherapy improves the outcome of CHOP chemotherapy in non-Hodgkin lymphoma-bearing mice | |
| Han et al. | Ginseng-derived nanoparticles potentiate immune checkpoint antibody efficacy by reprogramming the cold tumor microenvironment | |
| Venkatachalam et al. | Immune checkpoint inhibitors in prostate cancer | |
| Ardolino et al. | Cytokine therapy reverses NK cell anergy in MHC-deficient tumors | |
| Lucarini et al. | IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils | |
| Jin et al. | CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers | |
| Barber et al. | Treatment of multiple myeloma with adoptively transferred chimeric NKG2D receptor-expressing T cells | |
| Lion et al. | NK cells: key to success of DC-based cancer vaccines? | |
| Goulart et al. | T cells in pancreatic cancer stroma | |
| Macpherson et al. | Epithelial ovarian cancer and the immune system: biology, interactions, challenges and potential advances for immunotherapy | |
| Schuberth et al. | Effector memory and central memory NY-ESO-1-specific re-directed T cells for treatment of multiple myeloma | |
| Pampena et al. | Natural killer cells as helper cells in dendritic cell cancer vaccines | |
| Zhang et al. | Mechanisms of immunosuppression in colorectal cancer | |
| Vacchelli et al. | Trial watch: immunostimulatory cytokines | |
| Pesce et al. | Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor | |
| Malaisé et al. | KLRG1+ NK cells protect T-bet–deficient mice from pulmonary metastatic colorectal carcinoma | |
| Kim et al. | Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer | |
| Montico et al. | Exploiting a new strategy to induce immunogenic cell death to improve dendritic cell-based vaccines for lymphoma immunotherapy | |
| Chirullo et al. | Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response | |
| Wang et al. | Radiotherapy as a new player in immuno-oncology | |
| Tongu et al. | Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma | |
| Lucarini et al. | Dendritic cells: behind the scenes of T-cell infiltration into the tumor microenvironment | |
| Kim et al. | Hybrid Fc‐fused interleukin‐7 induces an inflamed tumor microenvironment and improves the efficacy of cancer immunotherapy | |
| Hamilton et al. | The impact of NK cell-based therapeutics for the treatment of lung cancer for biologics: targets and therapy | |
| Chung et al. | Emerging approaches for solid tumor treatment using CAR-T cell therapy |